Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-25-009797

CVP, Chief Financial Officer sold 7,700 shares at $84.47 ($650,412)

  • CVP, Chief Financial Officer acquired 7,700 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ullem Scott B. CVP, Chief Financial Officer 2025-12-09 Option exercise 10b5-1 +7,700 $59.26 $456,277 47,598 D: show line 1 in the form
Ullem Scott B. CVP, Chief Financial Officer 2025-12-09 Sale 10b5-1 −7,700 $84.47 $650,412 39,898 D: show line 2 in the form
Open-market sales · 7,700 sh · avg $84.47 · $650,412

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ullem Scott B. CVP, Chief Financial Officer 2025-12-09 Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 −7,700 39,000 D: show line 3 in the form
Loading xslF345X05/doc4.xml…